| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |